Logo image of KDA.CA

KDA GROUP INC (KDA.CA) Stock Fundamental Analysis

TSX-V:KDA - TSX Venture Exchange - CA48669F1071 - Common Stock - Currency: CAD

0.25  -0.01 (-1.96%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to KDA. KDA was compared to 8 industry peers in the Health Care Technology industry. While KDA seems to be doing ok healthwise, there are quite some concerns on its profitability. KDA does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

KDA had negative earnings in the past year.
KDA had a negative operating cash flow in the past year.
In multiple years KDA reported negative net income over the last 5 years.
In multiple years KDA reported negative operating cash flow during the last 5 years.
KDA.CA Yearly Net Income VS EBIT VS OCF VS FCFKDA.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M 15M

1.2 Ratios

KDA has a Return On Assets of -61.45%. This is in the lower half of the industry: KDA underperforms 62.50% of its industry peers.
With a decent Return On Equity value of -65.87%, KDA is doing good in the industry, outperforming 62.50% of the companies in the same industry.
Industry RankSector Rank
ROA -61.45%
ROE -65.87%
ROIC N/A
ROA(3y)2.11%
ROA(5y)-2.55%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
KDA.CA Yearly ROA, ROE, ROICKDA.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K 2K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for KDA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
KDA.CA Yearly Profit, Operating, Gross MarginsKDA.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5K 10K

More info and screens

6

2. Health

2.1 Basic Checks

KDA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, KDA has more shares outstanding
KDA has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, KDA has an improved debt to assets ratio.
KDA.CA Yearly Shares OutstandingKDA.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
KDA.CA Yearly Total Debt VS Total AssetsKDA.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

An Altman-Z score of 26.83 indicates that KDA is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 26.83, KDA belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
A Debt/Equity ratio of 0.06 indicates that KDA is not too dependend on debt financing.
KDA has a better Debt to Equity ratio (0.06) than 75.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Altman-Z 26.83
ROIC/WACCN/A
WACC9.27%
KDA.CA Yearly LT Debt VS Equity VS FCFKDA.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M 15M

2.3 Liquidity

KDA has a Current Ratio of 2.50. This indicates that KDA is financially healthy and has no problem in meeting its short term obligations.
KDA has a Current ratio of 2.50. This is amongst the best in the industry. KDA outperforms 87.50% of its industry peers.
A Quick Ratio of 2.50 indicates that KDA has no problem at all paying its short term obligations.
KDA's Quick ratio of 2.50 is amongst the best of the industry. KDA outperforms 87.50% of its industry peers.
Industry RankSector Rank
Current Ratio 2.5
Quick Ratio 2.5
KDA.CA Yearly Current Assets VS Current LiabilitesKDA.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

0

3. Growth

3.1 Past

KDA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -167.87%.
The Revenue for KDA has decreased by -24.65% in the past year. This is quite bad
The Revenue for KDA have been decreasing by -63.61% on average. This is quite bad
EPS 1Y (TTM)-167.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-28.75%
Revenue 1Y (TTM)-24.65%
Revenue growth 3Y-81.78%
Revenue growth 5Y-63.61%
Sales Q2Q%-13.28%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
KDA.CA Yearly Revenue VS EstimatesKDA.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for KDA. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
KDA.CA Price Earnings VS Forward Price EarningsKDA.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
KDA.CA Per share dataKDA.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 -0.02 0.04 -0.04 0.06

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for KDA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

KDA GROUP INC

TSX-V:KDA (4/30/2025, 7:00:00 PM)

0.25

-0.01 (-1.96%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)03-14 2025-03-14
Earnings (Next)07-18 2025-07-18
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners12.72%
Ins Owner ChangeN/A
Market Cap46.17M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 329.12
P/FCF N/A
P/OCF N/A
P/B 3.7
P/tB 36.22
EV/EBITDA N/A
EPS(TTM)-0.05
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0
BVpS0.07
TBVpS0.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -61.45%
ROE -65.87%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)2.11%
ROA(5y)-2.55%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 49.55%
Cap/Sales 1400.21%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.5
Quick Ratio 2.5
Altman-Z 26.83
F-Score3
WACC9.27%
ROIC/WACCN/A
Cap/Depr(3y)390.7%
Cap/Depr(5y)342.37%
Cap/Sales(3y)1339.12%
Cap/Sales(5y)805.67%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-167.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-28.75%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-24.65%
Revenue growth 3Y-81.78%
Revenue growth 5Y-63.61%
Sales Q2Q%-13.28%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-54.28%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-956.46%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-131.41%
OCF growth 3YN/A
OCF growth 5YN/A